Interleukin 36 receptor antagonist

Interleukin 36 receptor antagonist (IL-36Ra) is a protein that in humans is encoded by the IL36RN gene. It is a member of the interleukin family, a group of cytokines that play a crucial role in the immune system. IL-36Ra is specifically an antagonist of the interleukin 36 receptor, meaning it blocks the action of interleukin 36.

Function

IL-36Ra is part of the interleukin-1 cytokine family. This cytokine can inhibit the activity of interleukin-36 (IL-36) when bound to the interleukin 1 receptor-like 2 (IL1RL2/IL-1Rrp2). The inhibition of IL-36 activity leads to a reduction in the production of pro-inflammatory cytokines and chemokines, thus playing an important role in immune responses and inflammation.

Clinical significance

Mutations in the IL36RN gene are associated with a group of rare autoinflammatory diseases known as deficiency of the interleukin-36-receptor antagonist (DITRA). These diseases are characterized by recurrent skin pustules and fever, and can also involve other organs.

Research

Research into IL-36Ra is ongoing, with studies investigating its role in various diseases, including psoriasis, rheumatoid arthritis, and inflammatory bowel disease. Understanding the function of IL-36Ra and its receptor could potentially lead to new treatments for these and other inflammatory diseases.

See also

• Interleukin 36
• Interleukin 1 receptor-like 2
• Deficiency of the interleukin-36-receptor antagonist

References

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian